-Jacques Lelorier Researcher Activity Profile

Research Author Detailed Information 

Jacques Lelorier Publication Rate By Year

Jacques Lelorier has published 1 paper(s) in 2003, 1 paper(s) in 2004, 2 paper(s) in 2006, 7 paper(s) in 2007, 5 paper(s) in 2008, for a total of 16 research publications in total.

Jacques J Lelorier Author Information

LAST NAME: lelorier

FIRST NAME: jacques

INITIALS: J

AFFILIATION:

Papers

Jacques Lelorier's Publication Record

1. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada. Year Published: 2007
Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada. marshd@mcmaster.ca
2. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada. Year Published: 2007
Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada. marshd@mcmaster.ca
3. Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study. Year Published: 2007
4. Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study. Year Published: 2007
5. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada. Year Published: 2007
Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada. marshd@mcmaster.ca
6. Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs). Year Published: 2008
7. Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs). Year Published: 2008
Research group in Pharmacoepidemiology and Pharmacoeconomics, Research Center, Centre Hospitalier de l'Université de Montréal - Hôtel-Dieu (CHUM), Montréal, Québec.
8. Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study. Year Published: 2007
Pharmacoepidemiology and Pharmacoeconomics Research Unit, CHUM-Hôtel-Dieu, Montreal, Quebec, Canada.
9. Restrictive access to clopidogrel and mortality following coronary stent implantation. Year Published: 2008
Pharmaco-economics and pharmaco-epidemiology unit, Centre Hospitalier de l'Université de Montréal Research Centre, Université de Montréal, Montréal, Que.
10. Restrictive access to clopidogrel and mortality following coronary stent implantation. Year Published: 2008
Pharmaco-economics and pharmaco-epidemiology unit, Centre Hospitalier de l'Université de Montréal Research Centre, Université de Montréal, Montréal, Que.
11. Statins and cancer risk. Year Published: 2008
Department of Social and Preventive Medicine, University of Montreal, Quebec, Canada.
12. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Year Published: 2003
13. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue. Year Published: 2004
14. The value of lowering blood pressure. Year Published: 2006
Centre de recherche, Hotel-Dieu, CHUM, Montreal, Quebec. jacques.le.lorier@umontreal.ca
15. Treatment of dyslipidemia: we don't know all we think we know. Year Published: 2006
16. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. Year Published: 2007